deferoxamine has been researched along with salicylaldehyde isonicotinoyl hydrazone in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (75.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byczko, Z; Horackova, M; Ponka, P | 1 |
Creighton-Gutteridge, M; Tyrrell, RM | 1 |
Domb, A; Golenser, J; Kremsner, P; Leshem, B; Luty, A; Mordechai-Daniel, T | 1 |
Brunk, UT; Gustafsson, B; Kurz, T | 1 |
Bast, A; den Hartog, GJ; Kaiserová, H; Kvasnicková, E; Schröterová, L; Simůnek, T | 1 |
Kruszewski, M; Lewandowska, H; Meczyńska, S; Sadło, J; Sochanowicz, B | 1 |
Cabantchik, ZI; Kikkeri, R; Shanzer, A; Shvartsman, M | 1 |
Kruszewski, M; Lewandowska, H; Meczynska, S; Sadlo, J; Sochanowicz, B | 1 |
Cao, Y; Li, Y; Liu, N; Lu, Z; Nie, G; Ponka, P; Soe-Lin, S; Tao, Y; Zhang, Z; Zhao, B | 1 |
Kovacevic, Z; Richardson, DR; Yu, Y | 1 |
Bendová, P; Hašková, P; Hrušková, K; Jansová, H; Kovaříková, P; Macková, E; Simůnek, T; Vávrová, A; Vávrová, K | 1 |
Haskova, P; Jansova, H; Kalinowski, DS; Machacek, M; Potuckova, E; Richardson, DR; Richardson, V; Simunek, T; Tichotova, L; Vavrova, A | 1 |
12 other study(ies) available for deferoxamine and salicylaldehyde isonicotinoyl hydrazone
Article | Year |
---|---|
The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.
Topics: Action Potentials; Aldehydes; Amiloride; Animals; Calcium Channels; Cell Size; Cells, Cultured; Deferoxamine; Guinea Pigs; Hydrazones; Hydrogen Peroxide; Iron Chelating Agents; Myocardium; Oxidative Stress; Patch-Clamp Techniques; Sodium-Hydrogen Exchangers | 2000 |
A novel iron chelator that does not induce HIF-1 activity.
Topics: Aldehydes; Cell Hypoxia; Deferoxamine; DNA-Binding Proteins; Fibroblasts; Humans; Hydrazones; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron; Iron Chelating Agents; Mutation; Nuclear Proteins; Phenols; RNA, Messenger; Serine; Skin; Transcription Factors | 2002 |
Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
Topics: Aldehydes; Animals; B-Lymphocytes; Cells, Cultured; Deferoxamine; Disease Models, Animal; Humans; Hydrazones; Interleukin-10; Iron Chelating Agents; Leukocytes, Mononuclear; Luminescence; Malaria; Mice; Plasmodium; Plasmodium falciparum; Survival Analysis; T-Lymphocytes; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
Topics: Aldehydes; Apoptosis; Cell Proliferation; Chelating Agents; Deferoxamine; Endocytosis; Hydrazones; Hydrogen Peroxide; Iron; Iron Chelating Agents; Lysosomes; Membrane Potentials; Models, Biological; Necrosis; Oxidants; Oxidative Stress | 2006 |
Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
Topics: Aldehydes; Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deferoxamine; Doxorubicin; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrazones; Hydrogen Peroxide; Iron; Iron Chelating Agents; Iron Compounds; Isoniazid; Lipid Peroxidation; Lung Neoplasms; Oxidative Stress; Pyridoxal; Razoxane; Time Factors | 2006 |
Crucial role of lysosomal iron in the formation of dinitrosyl iron complexes in vivo.
Topics: Aldehydes; Ammonium Chloride; Cell Fractionation; Cell Line; Deferoxamine; Electron Spin Resonance Spectroscopy; Humans; Hydrazones; Iron; Iron Chelating Agents; Lysosomes; Nitric Oxide Donors; Nitrogen Oxides | 2007 |
Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.
Topics: Aldehydes; Animals; Biological Transport; Cell Line; Cytosol; Deferoxamine; Egtazic Acid; Fluoresceins; Fluorescent Dyes; Fluorometry; Hydrazones; Iron; Iron Chelating Agents; Microscopy, Fluorescence; Mitochondria; Models, Biological; Myocytes, Cardiac; Protein Binding; Rhodamines; Spectrometry, Fluorescence; Transferrin | 2007 |
Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
Topics: Aldehydes; Deferoxamine; Electron Spin Resonance Spectroscopy; Humans; Hydrazones; Iron; Iron Chelating Agents; K562 Cells; Nitric Oxide; Nitrogen Oxides | 2008 |
Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism.
Topics: Aldehydes; Apoptosis; Base Sequence; Blotting, Western; Cell Line, Tumor; Deferoxamine; DNA Primers; Enzyme-Linked Immunosorbent Assay; Ferritins; Homeostasis; Humans; Hydrazones; Iron Chelating Agents; Lysosomes; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; tert-Butylhydroperoxide | 2009 |
Chelators to the rescue: different horses for different courses!
Topics: Aldehydes; Animals; Deferoxamine; Humans; Hydrazones; Iron Chelating Agents; Iron Overload; Isoniazid; Myocardial Reperfusion Injury; Neoplasms; Pyridines; Pyridoxal; Rats; Reactive Oxygen Species; Thiosemicarbazones | 2011 |
Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
Topics: Aldehydes; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Caspases; Cell Cycle; Cell Line, Tumor; Deferoxamine; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Ketones; Membrane Potential, Mitochondrial; Oxidation-Reduction | 2012 |
Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
Topics: Aldehydes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cyclophosphamide; Deferoxamine; Doxorubicin; Drug Synergism; Fluorouracil; Humans; Hydrazones; Iron Chelating Agents; MCF-7 Cells; Methotrexate; Paclitaxel; Tamoxifen; Thiosemicarbazones | 2014 |